Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov site revision displayed in the footer was updated from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check25 days agoChange DetectedThe record history now includes a new version submitted on 2026-10-13, with a study-status update posted the following day. An NIH notice about terminology changes also appears on the page.SummaryDifference0.5%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check60 days agoChange DetectedA new site revision entry (v3.7.0) has been added to the history, updating the page's underlying platform version.SummaryDifference0.0%

- Check74 days agoChange DetectedNew site revision label (v3.6.6) appears, replacing the previous v3.6.5. This indicates a routine system update to the page without altering study data or visible content.SummaryDifference0.0%

- Check95 days agoChange DetectedThe record history now shows Revision: v3.6.5 as the latest version, replacing the previous v3.6.4, indicating an update to the page's revision history display.SummaryDifference0.0%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.